ライフサイエンスコーパス: unvaccinated

1 accine exposure status (fully vaccinated and unvaccinated).

2 e patients were eligible for vaccination but unvaccinated).

3 the era after elimination were intentionally unvaccinated.

4 % among those vaccinated and 34% among those unvaccinated.

5 to the camps in 2011, and 1027 (79.6%) were unvaccinated.

6 on, and a total of 8-12 million children are unvaccinated.

7 re 95%-97% and 90%, respectively, with 3%-5% unvaccinated.

8 cinated <7 or <14 days prior to admission as unvaccinated.

9 ients were vaccinated, and 114 patients were unvaccinated.

10 208,882 (85%) people were unvaccinated.

11 unity and, hence, indirect protection of the unvaccinated.

12 1 (4%) had received 1 dose, and 5 (19%) were unvaccinated.

13 unvaccinated individuals were intentionally unvaccinated.

14 tients (46%) were female, and 340 (89%) were unvaccinated.

15 0 person-years; 95% CI, 18.7-26.6) among the unvaccinated.

16 cine twice, 1 was vaccinated once, and 1 was unvaccinated.

17 most half the cattle aged < 24 months remain unvaccinated.

18 al mass campaigns, with a catch-up targeting unvaccinated 1- to 4-year-olds.

19 (>/=1 dose) (79.1 per 1000 person-years) vs unvaccinated (125.7 per 1000 person-years) females.

20 e cohort, the mothers of 55048 children were unvaccinated, 349 mothers were vaccinated in the first t

21 utable to the vaccination program were among unvaccinated 5-24 year-olds.

22 dent risk factors for measles included being unvaccinated (adjusted matched odds ratio [aMOR] 2.0, P

23 inconsistent with the numbers of cases among unvaccinated adolescents and adults in the new populatio

24 ccinees, whereas 2 cases were reported among unvaccinated adult SLSJ residents, and a third case in a

25 inate against hepatitis B virus (HBV) in all unvaccinated adults (including pregnant women) at risk f

26 Unvaccinated adults also experienced comparable reductio

27 otavirus infection and AGE in vaccinated and unvaccinated age groups within 1 year of introducing an

28 e the indirect protection afforded by PCV in unvaccinated age groups, including those in high-HIV-pre

29 outbreak of measles that originated from two unvaccinated Amish men in whom measles was incubating at

30 s rates were 3.3 per 100 000 person-years in unvaccinated and 1.3 per 100 000 person-years in vaccina

31 w-up was 41 years (IQR 32-49) for 83 421 BCG-unvaccinated and 44 years (41-46) for 297 905 vaccinated

32 vider diagnosis of "definite HZ" was 93% for unvaccinated and 79% for vaccinated children.

33 y protective response is virtually absent in unvaccinated and BCG-vaccinated animals after challenge.

34 on vaccines and changes in the proportion of unvaccinated and fully vaccinated children.

35 The attack rates among unvaccinated and fully vaccinated students were 82% and

36 lated by comparing consultation rates in the unvaccinated and vaccinated groups, adjusted for the lis

37 bone marrow following gp120 boosting of the unvaccinated and vaccinated macaque groups.

38 stillbirths per 100 000 pregnancy-days among unvaccinated and vaccinated women, respectively.

39 and immune people (who may be vaccinated or unvaccinated); and incorporates seasonal transmission an

40 e transient in vaccinated animals than in an unvaccinated animal.

41 f tissue, respectively, compared to those in unvaccinated animals (P < 0.0001).

42 007), tended to be higher in vaccinated than unvaccinated anti-HBc-positive subjects (16 of 334 [4.8%

43 OBI frequency was lower in vaccinated than unvaccinated antibody to hepatitis B core antigen (anti-

44 ed-exposed (adjusted odds ratio [aOR], 2.2), unvaccinated (aOR, 3.7), underweight (aOR, 6.3), and too

45 In addition, we show the risk of unvaccinated badger cubs, but not adults, testing positi

46 gime of unintended consequences, wherein the unvaccinated bear an increased disease burden.

47 HZV-vaccinated beneficiaries were matched to unvaccinated beneficiaries (primary analysis) and to HZV

48 beneficiaries (primary analysis) and to HZV-unvaccinated beneficiaries who had received pneumococcal

49 F, and rAPMV3-HN) were protective, while all unvaccinated birds succumbed to death.

50 irth cohorts was significantly lower than in unvaccinated birth cohorts among patients 15-24 years ol

51 of having PRN(-) B. pertussis compared with unvaccinated case-patients (adjusted OR = 2.2; 95% confi

52 lder was underpowered because there were few unvaccinated cases and controls.

53 GPs of eligible but unvaccinated cases with comorbidities were mostly unawar

54 Among the 10 949 unvaccinated cases, 213 (1.9%) escaped mandatory vaccina

55 ly better for vaccinated cases compared with unvaccinated cases; however, no significant modification

56 e than unvaccinated immunocompetent mice and unvaccinated CD4-depleted mice remained persistently inf

57 adult SLSJ residents, and a third case in an unvaccinated child who had stayed in the region during t

58 -strain) and 230 per 100,000 person-years in unvaccinated children (wild-type only).

59 Within 7 years of follow-up, 131 unvaccinated children and 2117 vaccinated children were

60 declines occurred in vaccinated children and unvaccinated children and adults (through indirect prote

61 were similar to the observed changes in PCV-unvaccinated children and adults, but not among children

62 tlements housed a large number of previously unvaccinated children and potentially served as reservoi

63 Unvaccinated children contribute to accumulation of susc

64 es of diarrhea-associated health care use in unvaccinated children in the period from January through

65 argest geographically concentrated cohort of unvaccinated children in the world.

66 Herd immunity for unvaccinated children may occur in schools with vaccinat

67 Unvaccinated children missed more school days than vacci

68 s among vaccinated children as compared with unvaccinated children were as follows: hospitalization f

69 Unvaccinated children were indirectly protected in the s

70 nation strategies and indirect protection of unvaccinated children will result in a large population

71 ndicators (eg, decreasing the number of DTP3-unvaccinated children) as well as program process indica

72 Indirect benefits (in unvaccinated children) were seen in 2007-2008 but not in

73 Compared to unvaccinated children, children who were fully vaccinate

74 in California occurred at a high rate among unvaccinated children, particularly those infected durin

75 he year following vaccination, compared with unvaccinated children.

76 disease were observed in both vaccinated and unvaccinated children.

77 in vaccinated children was 79% lower than in unvaccinated children.

78 omputed HZ incidence rates in vaccinated and unvaccinated children.

79 creased substantially in both vaccinated and unvaccinated children.

80 ter in life (HR, 1.01; 95% CI, 0.66-1.56) vs unvaccinated children.

81 icella or herpes zoster in vaccinated versus unvaccinated children.

82 Study subjects were divided into unvaccinated cohorts (born before 1984) and vaccinated c

83 sAg-negative subjects declined from 160.7 in unvaccinated cohorts to 11.5 in vaccinated cohorts.

84 re 91 and 583 HZ cases in the vaccinated and unvaccinated cohorts, respectively, yielding an incidenc

85 per 1000 person-years in the vaccinated and unvaccinated cohorts, respectively.

86 %, compared with cytology-based screening in unvaccinated cohorts.

87 iagnosis by 18% and of death by 20%, even in unvaccinated cohorts.

88 Group 2 (n = 30) came from unvaccinated communities and Group 3 (n = 39) came from

89 o received PCV7 after 6 months and came from unvaccinated communities.

90 have received rotavirus vaccine (33/44 [73%] unvaccinated) compared with rotavirus-negative children

91 in recipients after their first OPV dose or unvaccinated contacts (81%).

92 als, and readily transmitted B. pertussis to unvaccinated contacts.

93 linical outcome was compared with that of an unvaccinated, contemporary group of patients who had und

94 esponse profile were protected compared with unvaccinated control animals (P = 0.026).

95 virus replication (P < .01) relative to the unvaccinated control animals.

96 licular helper CD4 T cells compared with the unvaccinated control group.

97 respectively, whereas it was 26/31 (81%) in unvaccinated control pups (P < 0.0001 for both groups ve

98 converters survived virus challenge, whereas unvaccinated controls and vaccinated nonseroconverters l

99 In contrast, highly viremic, unvaccinated controls did not develop detectable Abs aga

100 ques that were vaccinated with SIVmac239 and unvaccinated controls to determine whether the SIVsmE660

101 n vaccinated patients compared to placebo or unvaccinated controls, although this reached significanc

102 Unlike two of two unvaccinated controls, two of the four vaccinated monkey

103 wing RhCMV challenge compared to shedding in unvaccinated controls.

104 week 12 after the first vaccination and to 6 unvaccinated controls.

105 vaccine before the LTPS began, there were no unvaccinated controls.

106 a delay in time to treatment, compared with unvaccinated controls.

107 ts at age 2-4 years together with a group of unvaccinated controls.

108 ction in the setpoint viral load compared to unvaccinated controls.

109 compromised patie nts compared to placebo or unvaccinated controls.

110 d influenza vaccination, and from 20 healthy unvaccinated controls.

111 mRNA levels in challenged mice than those in unvaccinated controls.

112 ocial group had been vaccinated, the risk to unvaccinated cubs was reduced by 79% (Odds ratio = 0.21,

113 badgers and an indirect protective effect in unvaccinated cubs.

114 th detailed vaccination data, 574 cases were unvaccinated despite being vaccine eligible and 405 (70.

115 ovember 2010, NmA carriage prevalence in the unvaccinated districts was comparable to the baseline es

116 tidis (NmX) dominated in both vaccinated and unvaccinated districts.

117 pathogen of dogs, causing high mortality in unvaccinated dogs.

118 the HBV vaccine) was the dominant strain in unvaccinated donors.

119 ally significant liver injury developed in 2 unvaccinated donors.

120 ed >/=1 mumps-containing vaccine, 1 (2%) was unvaccinated due to religious exemption, and 1 (2%) had

121 mation on vaccination status, 222 (47%) were unvaccinated; estimated VE was 74%.

122 M. tuberculosis infection in both humans and unvaccinated experimental animal models.

123 ytology result was lower among vaccinated vs unvaccinated females (hazard ratio [HR], 0.64; 95% CI, 0

124 The decrease in 4vHPV-type prevalence among unvaccinated females suggests herd protection.

125 V) prevalence among HPV-16/18-vaccinated and unvaccinated Finnish male adolescents participating in c

126 tions, a large connected cluster of children unvaccinated for measles will accumulate across Guinea,

127 ved at least 1 dose of vaccine compared with unvaccinated girls was 0.12, 0.22, 0.25, and 0.62 for th

128 to incident cases of GWs, and vaccinated and unvaccinated girls were compared using Cox proportional

129 ir NAb titers were 5- to 30-fold higher than unvaccinated girls.

130 28% in the vaccinated group and 5.34% in the unvaccinated group (P < .05).

131 0.0 (9.8-10.2) per 1,000 person-years in the unvaccinated group and 5.4 (95% CI 4.6-6.4) per 1,000 pe

132 For the consultation outcome, the unvaccinated group was split into individuals before vac

133 vaccinated patients than for a contemporary unvaccinated group, suggesting that a randomized trial o

134 rior survival compared with the contemporary unvaccinated group.

135 ces were detected between the vaccinated and unvaccinated groups in risk for inpatient visits (rate r

136 , 0.97-1.09); 8.4% of vaccinated and 8.3% of unvaccinated had an SGA birth (adjusted RR, 1.00; 95% CI

137 orter length of ICU stay than those who were unvaccinated (hazard ratio for discharge, 1.84; 95% conf

138 Unvaccinated health care personnel are at increased risk

139 s low overall, with approximately 59 million unvaccinated high-risk working-age adults.

140 a vaccinated with 6MHP to that of a group of unvaccinated historical controls.

141 type colonization reduction, including among unvaccinated HIV-infected women.

142 en strains that cause more severe disease in unvaccinated hosts.

143 Thirty-seven percent of the unvaccinated households with HBsAg carriers were aware o

144 mice had significantly faster clearance than unvaccinated immunocompetent mice and unvaccinated CD4-d

145 children's health and safety that remaining unvaccinated in a predominantly vaccine-protected commun

146 s significantly reduced in vaccinated versus unvaccinated individuals (0.11% v 1.61%; Padj = .008), c

147 ied by age; the highest rates occurred among unvaccinated individuals aged 25-39 years (2.33/100 000)

148 Unvaccinated individuals born in 1995 had a reduced odds

149 ccine-specific and cross-protective types in unvaccinated individuals born in 1995.

150 nce in disease burden between vaccinated and unvaccinated individuals can be ascribed to the vaccine-

151 A total of 1,414 unvaccinated individuals had baseline T-cell measurement

152 confidence interval [CI], 5.9-6.8), and for unvaccinated individuals it was 4606 in 355,659 person-y

153 Unvaccinated individuals remain the immunization priorit

154 ation has resulted in declines in disease in unvaccinated individuals through decreasing pathogen cir

155 8 of these outbreaks from 59% through 93% of unvaccinated individuals were intentionally unvaccinated

156 clinical symptoms and laboratory results for unvaccinated individuals with acute measles and individu

157 VZV transmission was highest from unvaccinated individuals with sporadic varicella (P < .0

158 measles in vaccinated individuals)/(risk in unvaccinated individuals)] x 100%.

159 ge of group A meningococci in vaccinated and unvaccinated individuals, demonstrating the vaccine's ab

160 In unvaccinated individuals, induced protein 10 (IP-10), in

161 tries was enhanced by indirect protection of unvaccinated individuals, mediated by reduced nasopharyn

162 equilibrium anti-HBV antibody levels, as in unvaccinated individuals, when a strong cellular immune

163 cell function and phenotype in 52 previously unvaccinated individuals.

164 er and PHN were determined in vaccinated and unvaccinated individuals.

165 vated rabies virus in vaccinated, but not in unvaccinated, individuals.

166 The propensity to infect unvaccinated infants and those at risk for insufficient

167 ime in 1-year-olds (from 87.1% to 26.5%), as unvaccinated infants reached 1 year of age.

168 Protection of unvaccinated infants requires avoidance of travel to end

169 The numbers would be substantially higher if unvaccinated infants, adolescents, and adult populations

170 nths of age had a lower risk of measles than unvaccinated infants.

171 senteric lymph nodes of vaccinated infected, unvaccinated infected, and uninfected macaques identifie

172 n vaccinated (IR 1.14, 95% CI 0.75-1.74) and unvaccinated (IR 1.78, 95% CI 1.68-1.88) individuals dur

173 Three vaccinated and 10 unvaccinated laboratory-confirmed cases occurred over ob

174 ositively correlated with plasma viremia and unvaccinated macaques had increased plasma cells and pla

175 pe (Env) sequences from 49 vaccinated and 15 unvaccinated macaques were compared to each other, we we

176 The prevalence of 4vHPV genotypes among 511 unvaccinated male subjects was significantly lower in th

177 t of the program impact on HPV prevalence in unvaccinated male subjects.

178 was compared between the vaccinated and the unvaccinated matched cohorts.

179 assessed by comparing the attack rates among unvaccinated members between high and low vaccine covera

180 vaccinated with HZ vaccine and three matched unvaccinated members were included.

181 A total of 1036 vaccinated and 5180 unvaccinated members were included.

182 ted cohort were age matched (1:3) to 227,283 unvaccinated members.

183 s significantly reduced in vaccinated versus unvaccinated men (0.0% v 2.13%; Padj = .007).

184 curred in 26 vaccinated men (6.0%) versus 25 unvaccinated men (5.8%), with an adjusted relative risk

185 These data suggest that unvaccinated men may have benefited from herd protection

186 o longitudinal data on genital infections in unvaccinated men.

187 n (median survival, 265 days), compared with unvaccinated mice (median survival, 150 days; P = .002),

188 ction against vaginal infection than seen in unvaccinated mice (P < .005).

189 s (median survival, 150 days; P = .050), and unvaccinated mice depleted of Treg cells (median surviva

190 arance of bacteria from the lung compared to unvaccinated mice.

191 /+);Pdx-1-Cre mice given LM-Kras, but not in unvaccinated mice.

192 ave been well documented among civilians and unvaccinated military recruits.

193 intravaginal transmissions in vaccinated and unvaccinated monkeys.

194 reakthrough compared with T/F Envs from four unvaccinated monkeys.

195 r odds of being born preterm than infants of unvaccinated mothers (adjusted odds ratio, 0.63 [95% CI,

196 irth was 51% less likely among vaccinated vs unvaccinated mothers (aHR, 0.49; 95% confidence interval

197 Among unvaccinated mothers (n = 1581), there were 191 (12.1%)

198 ts of H1N1-vaccinated mothers and infants of unvaccinated mothers was 45.1 g (95% CI, 1.8-88.3).

199 accinated mothers, and naive infants born to unvaccinated mothers were infected with B. pertussis at

200 hospital stays compared with infants born to unvaccinated mothers, after adjustment for chronological

201 Compared with infants of unvaccinated mothers, PT, FHA, and FIMs antibodies were

202 usted hazard ratios (aHRs) in vaccinated and unvaccinated mothers.

203 ikely to experience stillbirth compared with unvaccinated mothers.

204 n the orthodox communities, most of whom had unvaccinated mothers.

205 unit admission compared with infants born to unvaccinated mothers.

206 Previously vaccinated (n = 395) or unvaccinated (n = 149) male adolescents were enrolled in

207 Unvaccinated neonates and infants </=42 days old may ind

208 89.3% was seen in all age groups, including unvaccinated neonates and young infants.

209 In Tajikistan, the contribution of unvaccinated older children and adults to transmission w

210 neumococcal disease in young children and in unvaccinated older children and adults.

211 risk of hospitalization than those who were unvaccinated or single-dose recipients.

212 ce that this outbreak most likely arose from unvaccinated or under-vaccinated canines, not from a nov

213 among highly immunized populations, although unvaccinated or undervaccinated individuals continue to

214 substantial proportions (range, 24%-45%) of unvaccinated or undervaccinated individuals.

215 ver, these estimates are based on studies in unvaccinated or whole-cell pertussis-vaccinated children

216 k was 8.5% in the vaccinated and 8.9% in the unvaccinated (P = .83).

217 th rotavirus-negative children (81/136 [59%] unvaccinated) (P= .002).

218 e same decreases were also significant among unvaccinated participants (adjusted odds ratios, 0.44; [

219 paring disease outcomes in vaccinated versus unvaccinated participants via multivariable logistic reg

220 We compared the proportion of vaccinated and unvaccinated participants who were seropositive for the

221 for influenza virus among vaccinated versus unvaccinated participants.

222 tained at 7 months from 42 vaccinated and 24 unvaccinated participants.

223 test positivity among vaccinated compared to unvaccinated participants.

224 ped coughing significantly more rapidly than unvaccinated patients (adjusted hazard ratio, 1.7; 95% C

225 human papillomavirus (HPV) among previously unvaccinated patients aged 9-26 years; and consideration

226 nfluenza-related morbidity in vaccinated and unvaccinated patients and laboratory-confirmed cases of

227 2 (13.6%) vaccinated patients and 35 (30.7%) unvaccinated patients developed recurrent HGAIN.

228 Each vaccinated patient was matched to five unvaccinated patients on age, sex, and dialysis duration

229 This multicenter study included 34 unvaccinated patients with very severe or fatal confirme

230 for influenza among vaccinated patients and unvaccinated patients, adjusting for confounders.

231 pare disease severity between vaccinated and unvaccinated patients, adjusting for timing of antiviral

232 atients were matched 1:1 by sex and age with unvaccinated patients.

233 went hospitalization for HZ, compared with 6 unvaccinated patients.

234 ate of histologic HGAIN in vaccinated versus unvaccinated patients.

235 azards models for HZ comparing vaccinated vs unvaccinated patients.

236 e of PHN was compared between vaccinated and unvaccinated -patients.

237 Such evolution would put unvaccinated people at greater risk of severe disease.

238 age influenza infected 18% (95% CI 16-22) of unvaccinated people each winter.

239 y; vaccination protected both vaccinated and unvaccinated people in those clusters.

240 re maintained by poor vaccine responders and unvaccinated people.

241 [95% CI, 20.90-22.20] for the vaccinated and unvaccinated periods; adjusted rate ratio, 0.90 [95% CI,

242 in vaccinated persons and herd protection in unvaccinated persons is uncertain.

243 age), with rates significantly higher among unvaccinated persons than among persons who had received

244 He knows that the illness rate of unvaccinated persons weakly decreases as the vaccination

245 eillance for cases among contacts, including unvaccinated persons, no additional cases were identifie

246 e-serotype IPD in vaccinated children and in unvaccinated persons.

247 cy hospital admissions and 579 deaths in the unvaccinated population and 924 hospital admissions and

248 The decline in the unvaccinated population can be explained by herd protect

249 ge was eliminated in both the vaccinated and unvaccinated population from 3 weeks up to 13 months aft

250 s is due to increasing HPV prevalence in the unvaccinated population.

251 ne in MenC disease in the vaccinated and the unvaccinated population.

252 rs of the observation period occurred in the unvaccinated population.

253 ce of NmA carriage among both vaccinated and unvaccinated populations is consistent with a vaccine-in

254 cines (PCV) can indirectly reduce illness in unvaccinated populations is not known.

255 pected and confirmed cases in vaccinated and unvaccinated populations were estimated with negative bi

256 isease changes following PCV introduction in unvaccinated populations, updating the previous systemat

257 % (95% CI 55-59) in vaccinated compared with unvaccinated populations, with some heterogeneity observ

258 is virus has stalled, and MV still threatens unvaccinated populations.

259 l serotypes can also prevent transmission to unvaccinated populations.

260 also had a lower hazard of foetal loss than unvaccinated pregnancies in gestational weeks 9 through

261 s of foetal death for vaccinated compared to unvaccinated pregnancies were estimated for gestational

262 ince completion of the DTaP series, using an unvaccinated reference group, children with pertussis co

263 3285 adults: 1217 statin nonusers (37%), 903 unvaccinated statin nonusers (27%), 847 vaccinated stati

264 , 847 vaccinated statin users (26%), and 318 unvaccinated statin users (10%).

265 l [CI], 87%-97%) vs 37% (95% CI, 24%-51%) in unvaccinated students.

266 who received the recommended 2 doses and 52 unvaccinated students.

267 sed a cohort design including vaccinated and unvaccinated study participants.

268 ng HPV-16/18-vaccinated (4.1%) compared with unvaccinated subjects (10.1%) (P = .01).

269 = 0.072), and was higher in vaccinated than unvaccinated subjects seropositive for both antibody to

270 occal CAP (0.14 vs 0.26 among vaccinated and unvaccinated subjects, respectively), 1.45 for nonbacter

271 ferred reasonably across both vaccinated and unvaccinated subjects, with infections resulting from va

272 occurrence of OBI than natural infections in unvaccinated subjects.

273 lity following either HPV vaccination or, if unvaccinated, the first missed opportunity for HPV vacci

274 ar risk periods following vaccination and in unvaccinated time periods.

275 The rate among the unvaccinated was 11.6 cases per 1000 person-years (95% C

276 ior doses (38%; P = .009) or those currently unvaccinated with 1-2 prior doses (10%; P < .001).

277 among those who self-reported vaccination or unvaccinated women (1.76% and 15.0%, respectively).

278 men (4.2%) experienced PHN, compared with 75 unvaccinated women (10.4%), with an adjusted relative ri

279 delivery were 6.3% of vaccinated and 7.8% of unvaccinated women (adjusted RR, 1.03; 95% CI, 0.97-1.09

280 diagnosed in 6.1% of vaccinated and 5.5% of unvaccinated women (adjusted RR, 1.19; 95% CI, 1.13-1.26

281 ed women and 5 (18.5%, 95% CI 6.3-38.1) from unvaccinated women (P<0.0001).

282 olled for differences between vaccinated and unvaccinated women and influenza virus circulation.

283 atios for preterm birth in vaccinated versus unvaccinated women and the associated sample size requir

284 kinetics of maternal pertussis antibodies in unvaccinated women and their infants (group A; 86 mother

285 11, -16, and -18) among all, vaccinated, and unvaccinated women at waves 1, 2, and 3, adjusted for di

286 Unvaccinated women born between 1975 and 1990 were predi

287 r prevalence observed in both vaccinated and unvaccinated women compared with the prevaccine populati

288 statistically significantly less likely than unvaccinated women to have an infant born preterm during

289 eness for confirmed vaccinated compared with unvaccinated women was 95.93% (95% confidence interval [

290 vulvar HPV16/18 among HPV vaccinated versus unvaccinated women was calculated and compared to the ce

291 The mean (SD) ages of vaccinated and unvaccinated women were 31.6 (5.2) and 30.4 (5.6) years,

292 urrent infections with multiple HPV types in unvaccinated women who underwent cervical screening in N

293 om a population-based case-control study for unvaccinated women, and using a microsimulation model fo

294 tiveness in a community setting, and >30% in unvaccinated women, providing evidence of herd protectio

295 baseline differences between vaccinated and unvaccinated women.

296 les were collected from 77 vaccinated and 27 unvaccinated women.

297 en self-reporting vaccination, and 1893 from unvaccinated women.

298 to enhance current cervical screening among unvaccinated women.

299 , and from 32.5% to 22.0% (32.3% decline) in unvaccinated women.

300 An unvaccinated, young, female patient with measles confirm